Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema / Daniela Gompelmann, Hyun-Ju Lim, Ralf Eberhardt, Vasiliki Gerovasili, Felix J.F. Herth, Claus Peter Heussel, Monika Eichinger
BACKGROUND: Endoscopic valve implantation is an effective treatment for patients with advanced emphysema. Despite the minimally invasive procedure, valve placement is associated with risks, the most common of which is pneumothorax. This study was designed to identify predictors of pneumothorax following endoscopic valve implantation. - METHODS: Preinterventional clinical measures (vital capacity, forced expiratory volume in 1 second, residual volume, total lung capacity, 6-minute walk test), qualitative computed tomography (CT) parameters (fissure integrity, blebs/bulla, subpleural nodules, pleural adhesions, partial atelectasis, fibrotic bands, emphysema type) and quantitative CT parameters (volume and low attenuation volume of the target lobe and the ipsilateral untreated lobe, target air trapping, ipsilateral lobe volume/hemithorax volume, collapsibility of the target lobe and the ipsilateral untreated lobe) were retrospectively evaluated in patients who underwent endoscopic valve placement (n=129). Regression analysis was performed to compare those who developed pneumothorax following valve therapy (n=46) with those who developed target lobe volume reduction without pneumothorax (n=83). - FINDING: Low attenuation volume% of ipsilateral untreated lobe (odds ratio [OR] =1.08, P=0.001), ipsilateral untreated lobe volume/hemithorax volume (OR =0.93, P=0.017), emphysema type (OR =0.26, P=0.018), pleural adhesions (OR =0.33, P=0.012) and residual volume (OR =1.58, P=0.012) were found to be significant predictors of pneumothorax. Fissure integrity (OR =1.16, P=0.075) and 6-minute walk test (OR =1.05, P=0.077) were also indicative of pneumothorax. The model including the aforementioned parameters predicted whether a patient would experience a pneumothorax 84% of the time (area under the curve =0.84). - INTERPRETATION: Clinical and CT parameters provide a promising tool to effectively identify patients at high risk of pneumothorax following endoscopic valve therapy..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
1 August 2016 2016 |
---|---|
Erschienen: |
1 August 2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
The International journal of chronic obstructive pulmonary disease - 11(2016), Seite 1767-1773 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gompelmann, Daniela, 1982- [VerfasserIn] |
---|
Anmerkungen: |
Gesehen am 28.07.2020 |
---|
Umfang: |
7 |
---|
doi: |
10.2147/COPD.S106439 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1725701774 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1725701774 | ||
003 | DE-627 | ||
005 | 20230426183836.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200728s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/COPD.S106439 |2 doi | |
035 | |a (DE-627)1725701774 | ||
035 | |a (DE-599)KXP1725701774 | ||
035 | |a (OCoLC)1341348688 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Gompelmann, Daniela |d 1982- |e verfasserin |0 (DE-588)139007296 |0 (DE-627)607763914 |0 (DE-576)309888514 |4 aut | |
245 | 1 | 0 | |a Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema |c Daniela Gompelmann, Hyun-Ju Lim, Ralf Eberhardt, Vasiliki Gerovasili, Felix J.F. Herth, Claus Peter Heussel, Monika Eichinger |
264 | 1 | |c 1 August 2016 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 28.07.2020 | ||
520 | |a BACKGROUND: Endoscopic valve implantation is an effective treatment for patients with advanced emphysema. Despite the minimally invasive procedure, valve placement is associated with risks, the most common of which is pneumothorax. This study was designed to identify predictors of pneumothorax following endoscopic valve implantation. - METHODS: Preinterventional clinical measures (vital capacity, forced expiratory volume in 1 second, residual volume, total lung capacity, 6-minute walk test), qualitative computed tomography (CT) parameters (fissure integrity, blebs/bulla, subpleural nodules, pleural adhesions, partial atelectasis, fibrotic bands, emphysema type) and quantitative CT parameters (volume and low attenuation volume of the target lobe and the ipsilateral untreated lobe, target air trapping, ipsilateral lobe volume/hemithorax volume, collapsibility of the target lobe and the ipsilateral untreated lobe) were retrospectively evaluated in patients who underwent endoscopic valve placement (n=129). Regression analysis was performed to compare those who developed pneumothorax following valve therapy (n=46) with those who developed target lobe volume reduction without pneumothorax (n=83). - FINDING: Low attenuation volume% of ipsilateral untreated lobe (odds ratio [OR] =1.08, P=0.001), ipsilateral untreated lobe volume/hemithorax volume (OR =0.93, P=0.017), emphysema type (OR =0.26, P=0.018), pleural adhesions (OR =0.33, P=0.012) and residual volume (OR =1.58, P=0.012) were found to be significant predictors of pneumothorax. Fissure integrity (OR =1.16, P=0.075) and 6-minute walk test (OR =1.05, P=0.077) were also indicative of pneumothorax. The model including the aforementioned parameters predicted whether a patient would experience a pneumothorax 84% of the time (area under the curve =0.84). - INTERPRETATION: Clinical and CT parameters provide a promising tool to effectively identify patients at high risk of pneumothorax following endoscopic valve therapy. | ||
650 | 4 | |a Humans | |
650 | 4 | |a Female | |
650 | 4 | |a Male | |
650 | 4 | |a Middle Aged | |
650 | 4 | |a Aged | |
650 | 4 | |a Adult | |
650 | 4 | |a Aged, 80 and over | |
650 | 4 | |a Linear Models | |
650 | 4 | |a Bronchoscopy | |
650 | 4 | |a COPD | |
650 | 4 | |a Lung | |
650 | 4 | |a emphysema | |
650 | 4 | |a Pulmonary Emphysema | |
650 | 4 | |a Retrospective Studies | |
650 | 4 | |a Risk Factors | |
650 | 4 | |a Treatment Outcome | |
650 | 4 | |a valve therapy | |
650 | 4 | |a Vital Capacity | |
650 | 4 | |a Area Under Curve | |
650 | 4 | |a endoscopic lung volume reduction | |
650 | 4 | |a Exercise Tolerance | |
650 | 4 | |a Forced Expiratory Volume | |
650 | 4 | |a Logistic Models | |
650 | 4 | |a Multidetector Computed Tomography | |
650 | 4 | |a Odds Ratio | |
650 | 4 | |a pneumothorax | |
650 | 4 | |a Pneumothorax | |
650 | 4 | |a Predictive Value of Tests | |
650 | 4 | |a ROC Curve | |
650 | 4 | |a Severity of Illness Index | |
650 | 4 | |a Walk Test | |
700 | 1 | |a Lim, Hyun-ju |e verfasserin |0 (DE-588)1160311390 |0 (DE-627)1023457814 |0 (DE-576)505836254 |4 aut | |
700 | 1 | |a Eberhardt, Ralf |e verfasserin |0 (DE-588)1055080406 |0 (DE-627)792649133 |0 (DE-576)176462120 |4 aut | |
700 | 1 | |a Gerovasili, Vasiliki |e verfasserin |4 aut | |
700 | 1 | |a Herth, Felix |e verfasserin |0 (DE-588)1016095236 |0 (DE-627)705477568 |0 (DE-576)351509925 |4 aut | |
700 | 1 | |a Heußel, Claus Peter |e verfasserin |0 (DE-588)1048631389 |0 (DE-627)780769422 |0 (DE-576)40288146X |4 aut | |
700 | 1 | |a Eichinger, Monika |d 1964- |e verfasserin |0 (DE-588)1049617525 |0 (DE-627)78269117X |0 (DE-576)172609712 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The International journal of chronic obstructive pulmonary disease |d Albany, Auckland : DOVE Medical Press, 2006 |g 11(2016), Seite 1767-1773 |h Online-Ressource |w (DE-627)504104357 |w (DE-600)2212419-6 |w (DE-576)312706367 |x 1178-2005 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2016 |g pages:1767-1773 |g extent:7 |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2446 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
936 | u | w | |d 11 |j 2016 |h 1767-1773 |g 7 |
951 | |a AR | ||
952 | |d 11 |j 2016 |h 1767-1773 |g 7 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3731015307 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 28-07-20 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2016 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_7 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_7 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1513610376 |a Gompelmann, Daniela | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1444845233 |a Thoraxklinik Heidelberg gGmbH | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1575836246 |a Lim, Hyun-ju | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1444845233 |a Thoraxklinik Heidelberg gGmbH | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_2 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)1481154605 |a Eberhardt, Ralf | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1444845233 |a Thoraxklinik Heidelberg gGmbH | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s p |0 (DE-627)1476421528 |a Herth, Felix | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s k |0 (DE-627)1444845233 |a Thoraxklinik Heidelberg gGmbH | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |a pos_5 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s p |0 (DE-627)1472881788 |a Heußel, Claus Peter | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s k |0 (DE-627)1444845233 |a Thoraxklinik Heidelberg gGmbH | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |a pos_6 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s p |0 (DE-627)1473604982 |a Eichinger, Monika | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s k |0 (DE-627)1444845233 |a Thoraxklinik Heidelberg gGmbH | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s s |a pos_7 |